How tyrosine 15 phosphorylation inhibits the activity of cyclin-dependent kinase 2-cyclin A

Julie P I Welburn1, Julie A Tucker, Tim Johnson

  • 1AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TF, United Kingdom.

Insights

Inhibiting cyclin-dependent kinase 1 (CDK1) via Tyr-15 phosphorylation controls cell cycle entry into mitosis. Unlike CDK1, Tyr-15 phosphorylated CDK2 retains kinase activity, impacting cell cycle models.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinases (CDKs) are crucial regulators of the eukaryotic cell cycle.
  • Inhibitory phosphorylation, particularly at Tyr-15, is a key mechanism for controlling CDK activity and cell cycle progression.
  • Understanding these regulatory mechanisms is fundamental for comprehending cell cycle control and potential disruptions.

Purpose of the Study:

  • To investigate the mechanistic basis of inhibitory Tyr-15 phosphorylation in cyclin-dependent kinases.
  • To compare the effects of Tyr-15 phosphorylation on CDK1 and CDK2 activity.
  • To assess the implications of these findings for cell cycle regulation models.

Main Methods:

  • Kinetic analyses of CDK2-cyclin A complexes.
  • Crystallographic studies of CDK2-cyclin A complexes.
  • Biochemical assays to measure kinase and ATPase activity.

Main Results:

  • Tyr-15 phosphorylation of CDK1 inhibits its activity, regulating entry into mitosis and cell cycle progression.
  • Inhibition by Tyr-15 phosphorylation in CDK1 functions via steric hindrance of substrate binding and unfavorable ATP conformation.
  • Unlike CDK1, Tyr-15 phosphorylation of CDK2 does not significantly alter its ATP binding kinetics (Km) or intrinsic ATPase activity.
  • Tyr-15 phosphorylated CDK2 retains residual protein phosphorylation activity.

Conclusions:

  • The mechanism of cell cycle regulation by inhibitory Tyr-15 phosphorylation differs between CDK1 and CDK2.
  • Residual activity of Tyr-15 phosphorylated CDK2 necessitates its consideration in quantitative and qualitative cell cycle models.
  • These findings refine our understanding of CDK regulation and its role in cell cycle control.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...